
"Russia is one of the key markets for us and we are consistently looking to expand our product portfolio," Glenmark Pharmaceuticals Senior Vice President and Head - Asia, Russia and CIS region Csaba Kantor said.
from Moneycontrol Business News https://ift.tt/2oxcxB4
No comments:
Post a Comment